Published in J Clin Chem Clin Biochem on June 01, 1976
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature (1991) 7.98
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res (2001) 5.45
The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab (2001) 3.55
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A (1992) 3.01
A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science (1995) 2.78
Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci U S A (1997) 2.52
Side-effects of allergen-specific immunotherapy: a prospective multi-centre study. Clin Exp Allergy (2006) 2.36
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab (1999) 1.61
Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61
Partial rescue of PTH/PTHrP receptor knockout mice by targeted expression of the Jansen transgene. Endocrinology (2001) 1.61
Cloning and nucleotide sequences of the genes for the subunits of NAD-reducing hydrogenase of Alcaligenes eutrophus H16. J Bacteriol (1990) 1.60
Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84) Endocrinology (1995) 1.53
Thyroid hormones in the elderly sick: "T4 euthyroidism". Br Med J (1975) 1.49
CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology (2005) 1.45
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int (2006) 1.45
[Adverse effects of drugs in the elderly. Reasons for hospitalization]. Tidsskr Nor Laegeforen (1987) 1.42
Receptors for PTH and PTHrP: their biological importance and functional properties. Am J Physiol (1999) 1.40
Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet (2001) 1.37
Radioimmunoassay of triiodothyronine in unextracted human serum. Br Med J (1973) 1.36
Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology (1993) 1.36
Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. J Clin Microbiol (1999) 1.32
Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet (2001) 1.31
Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology (1993) 1.31
Biochemical signal transduction of mechanical strain in osteoblast-like cells. Biomaterials (1991) 1.29
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr (1988) 1.27
Functional analysis of the PTH/PTHrP network of ligands and receptors. Recent Prog Horm Res (1998) 1.19
Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction. J Biol Chem (1996) 1.18
Low serum L-T3 levels in the elderly sick: protein binding, thyroid and pituitary responsiveness, and reverse T3 concentrations. Clin Endocrinol (Oxf) (1977) 1.16
Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol Metab (2001) 1.15
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J (Clin Res Ed) (1984) 1.14
Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in man. Metabolism (1992) 1.14
Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy (2007) 1.14
Iguana-associated salmonellosis in children. Pediatr Infect Dis J (1995) 1.13
Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab (1990) 1.12
Dissociated loss of cold and warm sensibility during regional anaesthesia. Pflugers Arch (1974) 1.10
Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol (1997) 1.08
Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding. Endocrinology (1994) 1.08
[Ropivacaine for spinal anesthesia. A dose-finding study]. Anaesthesist (1996) 1.07
Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1--36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking. J Biol Chem (2001) 1.07
Cloning and characterization of the vitamin D receptor from Xenopus laevis. Endocrinology (1997) 1.06
In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. Bone (1993) 1.06
Inhibition of gastric secretion by calcitonin in man. Horm Metab Res (1971) 1.06
Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology (2001) 1.06
Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int (1998) 1.05
Cyclosporin in infiltrative eye disease. Lancet (1984) 1.05
[Calcitonin-induced inhibition of exocrine pancreatic secretion in man]. Dtsch Med Wochenschr (1971) 1.04
Conversion of thyroxine (T4) and triiodothyronine (T3) and the subcellular localisation of the converting enzyme. Clin Chim Acta (1975) 1.02
Infective endocarditis caused by Rothia dentocariosa. Ann Intern Med (1979) 1.02
Pseudohypoparathyroidism. New insights into an old disease. Endocrinol Metab Clin North Am (2000) 1.01
Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol (1991) 1.00
The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous. Biochem Biophys Res Commun (1994) 1.00
Dog-associated risk factors for human plague. Zoonoses Public Health (2008) 0.99
Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology (1997) 0.98
Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology (2002) 0.98
Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. J Biol Chem (1997) 0.98
Interaction of PTH and PTHrP with their receptors. Rev Endocr Metab Disord (2000) 0.96
Determinants of [Arg2]PTH-(1-34) binding and signaling in the transmembrane region of the parathyroid hormone receptor. Endocrinology (1994) 0.96
Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation. J Cell Biol (1993) 0.95
Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications. Exp Clin Endocrinol Diabetes (2008) 0.95
Rat liver iodothyronine monodeiodinase. Evaluation of the iodothyronine ligand-binding site. J Biol Chem (1986) 0.95
Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism. J Clin Endocrinol Metab (1996) 0.95
Pharmacokinetics of trimethoprim and its combination with sulfamethoxazole in man after single and chronic oral administration. Chemotherapy (1973) 0.95
Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. Endocrinology (1995) 0.94
Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts. J Bone Miner Res (1996) 0.94
Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects. Allergy (2012) 0.93
Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia. Mol Endocrinol (1997) 0.93
Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J Clin Endocrinol Metab (1989) 0.93
Temporal patterns of alpha 1-receptor stimulation regulate amplitude and frequency of calcium transients. Am J Physiol (1993) 0.92
Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors. Endocrinology (1996) 0.92
Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist. J Biol Chem (1996) 0.92
A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab (1999) 0.91
Detection and molecular typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks and in different patient samples from southwest Germany. Eur J Epidemiol (2001) 0.91
Truncation of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylyl cyclase but not phospholipase C. J Biol Chem (1995) 0.91
Inhibition of rat liver iodothyronine deiodinase. Interaction of aurones with the iodothyronine ligand-binding site. J Biol Chem (1986) 0.91
Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls. J Clin Invest (1995) 0.91
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL. Bone Marrow Transplant (2002) 0.91
Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology (2004) 0.91
Plasma triiodothyronine at the end of pregnancy, in the cord blood and in the first days of the newborn. Z Kinderheilkd (1973) 0.90
[Comparative studies of the local anaesthetic action of carticaine 1% and mepivacaine 1% (author's transl)]. Anaesthesist (1978) 0.90
Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab (1987) 0.90
Subcellular localization of thyroxine-5-deiodinase in rat liver. J Endocrinol Invest (1980) 0.90
Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies. J Biol Chem (1998) 0.90
Hepatic osteodystrophy in primary biliary cirrhosis: a possible defect in Kupffer cell mediated cleavage of parathyroid hormone. Clin Endocrinol (Oxf) (1983) 0.90
Somatic growth after kidney transplantation. Beneficial effect of cyclosporine in comparison with conventional immunosuppression. Am J Dis Child (1987) 0.89
Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred. Bone (2012) 0.89
A comparison of different compounds for TBG-blocking used in radioimmunoassay for tri-iodothyronine. Clin Chim Acta (1973) 0.89
Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis. J Biol Chem (2001) 0.88
Conversion of T4 to T3 and rT3 and their cytoplasmic binding: pH dependency. Clin Chim Acta (1977) 0.88
On antisense peptides: the parathyroid hormone as an experimental example and a critical theoretical view. Biochem Biophys Res Commun (1987) 0.87
Acute hyperparathyroidism. Clinical, laboratory and ultrastructural findings in a variant of primary hyperparathyroidism. Klin Wochenschr (1980) 0.87
Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function. Eur Respir J (2011) 0.87
Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int (1998) 0.87
The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b. J Infect Dis (1997) 0.86
[Sex difference related complication rates after spinal anaesthesia (author's transl)]. Reg Anaesth (1982) 0.86
Two frequent tetra-nucleotide repeat polymorphisms between VAPB and STX16 on chromosome 20q13. Mol Cell Probes (1999) 0.86
[A highly sensitive C-terminal specific radioimmunoassay for human parathormone as a routine method (author's transl)]. Dtsch Med Wochenschr (1976) 0.86